1. Home
  2. BGLC vs DEVS Comparison

BGLC vs DEVS Comparison

Compare BGLC & DEVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • DEVS
  • Stock Information
  • Founded
  • BGLC 2017
  • DEVS N/A
  • Country
  • BGLC Malaysia
  • DEVS Canada
  • Employees
  • BGLC N/A
  • DEVS N/A
  • Industry
  • BGLC Medical Specialities
  • DEVS
  • Sector
  • BGLC Health Care
  • DEVS
  • Exchange
  • BGLC Nasdaq
  • DEVS NYSE
  • Market Cap
  • BGLC 5.8M
  • DEVS 6.1M
  • IPO Year
  • BGLC N/A
  • DEVS N/A
  • Fundamental
  • Price
  • BGLC $2.67
  • DEVS $0.34
  • Analyst Decision
  • BGLC
  • DEVS
  • Analyst Count
  • BGLC 0
  • DEVS 0
  • Target Price
  • BGLC N/A
  • DEVS N/A
  • AVG Volume (30 Days)
  • BGLC 1.6M
  • DEVS 19.7M
  • Earning Date
  • BGLC 05-23-2025
  • DEVS 05-20-2025
  • Dividend Yield
  • BGLC N/A
  • DEVS N/A
  • EPS Growth
  • BGLC N/A
  • DEVS N/A
  • EPS
  • BGLC N/A
  • DEVS N/A
  • Revenue
  • BGLC $9,510,646.00
  • DEVS N/A
  • Revenue This Year
  • BGLC N/A
  • DEVS N/A
  • Revenue Next Year
  • BGLC N/A
  • DEVS N/A
  • P/E Ratio
  • BGLC N/A
  • DEVS N/A
  • Revenue Growth
  • BGLC N/A
  • DEVS N/A
  • 52 Week Low
  • BGLC $2.01
  • DEVS $0.18
  • 52 Week High
  • BGLC $8.40
  • DEVS $1.91
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 46.93
  • DEVS N/A
  • Support Level
  • BGLC $2.57
  • DEVS N/A
  • Resistance Level
  • BGLC $2.76
  • DEVS N/A
  • Average True Range (ATR)
  • BGLC 0.21
  • DEVS 0.00
  • MACD
  • BGLC 0.00
  • DEVS 0.00
  • Stochastic Oscillator
  • BGLC 20.24
  • DEVS 0.00

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About DEVS DEVVSTREAM CORP

DevvStream Corp is a technology-based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve its sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.

Share on Social Networks: